onSeptember 29, 2025

Months after cancer drug trial, Merus agrees to be bought at 41% premium

1 min read

Merus agreed to be bought for a 41% premium, months after a positive trial of a cancer drug.

onSeptember 29, 2025

7 views

Morgan Stanley expects Novo Nordisk Alzheimer trial to fail as it slashes rating

Write a Comment

“My husband jokes that he will never be able to retire because we do not own a home.”

1 Min Read

onSeptember 29, 2025

Gavekal Research predicts more stock repurchases are coming, representing an additional tailwind for the current bull market.

2 Min Read

onSeptember 29, 2025

Despite Warnings, Germany’s Merz Says Billions In Russian Assets Can Be Tapped To Force Putin To Accept Peace Via Remix News, German…